The Federal SBIR/STTR programs award over $2.4 million in high risk R&D funding annually to qualified small businesses. The process is complex with a steep learning curve, but the impact of receiving $millions in non-dilutive funding is worth the effort. This half-day session will provide an overview of SBIR/STTR funding, discuss eligibility requirements, and help participants determine whether or not they should take the next steps in pursuing this compelling source of non-dilutive funding.
NYCEDC is pleased to announce the 2013 inaugural class of the Bio & Health Tech Entrepreneurship Lab, a training and mentorship program for new life sciences and healthcare ventures based in NYC.
We are excited to launch this prestigious 6-month training and mentorship program for aspiring entrepreneurs in New York City’s life sciences and healthcare technology community.
Four New York City scientists have been awarded a total of $1 million in research funding to develop biomedical devices and products as winners of the third annual BioAccelerate NYC competition.
